A. Keith Stewart
- Molecular Biology top 5%
- Hematology top 0.5%
- Oncology top 2%
- Immunology top 5%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Hong ChangSuzanne TrudelDonna ReeceR S SchwartzP. Leif BergsagelZhihua LiXiao‐Yan WenArmand Keating
- Topics
- Multiple Myeloma Research and Treatments (49 papers)Protein Degradation and Inhibitors (23 papers)Lymphoma Diagnosis and Treatment (11 papers)
- Cited by
- HematologyOncologyGenetics
- Partner nations
- CanadaUnited StatesNew Zealand
In The Last Decade
A. Keith Stewart
98 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 2.4k
- Hematology 1.8k
- Oncology 1.4k
- Immunology 549
- Pathology and Forensic Medicine 483
Countries citing papers authored by A. Keith Stewart
This map shows the geographic impact of A. Keith Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Keith Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Keith Stewart more than expected).
Fields of papers citing papers by A. Keith Stewart
This network shows the impact of papers produced by A. Keith Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Keith Stewart. The network helps show where A. Keith Stewart may publish in the future.
Co-authorship network of co-authors of A. Keith Stewart
This figure shows the co-authorship network connecting the top 25 collaborators of A. Keith Stewart. A scholar is included among the top collaborators of A. Keith Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Keith Stewart. A. Keith Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | 12 | |
| 5 | 44 | |
| 6 | 10 | |
| 7 | 113 | |
| 8 | 70 | |
| 9 | 89 | |
| 10 | 47 | |
| 11 | 4 | |
| 12 | 29 | |
| 13 | 51 | |
| 14 | 63 | |
| 15 | 12 | |
| 16 | 16 | |
| 17 | Febrile neutropenia after hematopoietic stem cell mobilization with chemotherapy and G-CSF does not affect collection of adequate numbers of CD34+ cells. | 2 |
| 18 | 4 | |
| 19 | 16 | |
| 20 | 23 |
About A. Keith Stewart
A. Keith Stewart is a scholar working on Hematology, Genetics and Oncology, having authored 100 papers that have together received 3.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (49 papers), Protein Degradation and Inhibitors (23 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Hematology (1.8k citations), Oncology (1.4k citations) and Genetics (463 citations). A. Keith Stewart has collaborated with scholars based in Canada, United States and New Zealand. Frequent co-authors include Hong Chang, Suzanne Trudel, Donna Reece, R S Schwartz, P. Leif Bergsagel, Zhihua Li, Xiao‐Yan Wen, Armand Keating, Ellen Wei and Christine Chen. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.